Kocabas, N. A. Et Al. 2010. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , vol.25, no.4 , 218-227.

Kocabas, N. A., Faghel, C., Barreto, M., Kasper, S., Linotte, S., Mendlewicz, J., ... Noro, M.(2010). The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , vol.25, no.4, 218-227.

Kocabas, Neslihan Et Al. "The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study," INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , vol.25, no.4, 218-227, 2010

Kocabas, Neslihan A. Et Al. "The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study." INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , vol.25, no.4, pp.218-227, 2010

Kocabas, N. A. Et Al. (2010) . "The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study." INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , vol.25, no.4, pp.218-227.

@article{article, author={Neslihan Aygun Kocabas Et Al. }, title={The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study}, journal={INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY}, year=2010, pages={218-227} }